About Becton Dickinson and Co
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.bd.com/
Frequently Asked Questions
What is the 52-week range for BDX?
The 52-week high is $193.07 and the 52-week low is $127.59.
What is the P/E ratio for BDX?
The Price to Earnings (P/E) ratio is 51.31.
What is the dividend yield for BDX?
The indicated annual dividend yield is 1.59%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 3.80%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 4.52%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.10.
Analyst Recommendation Trends
Wall Street analyst consensus for BDX over the last few months:
Latest BDX News
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex
Medical-dental supplies see durable demand from specialty care, AI and aging trends, with McKesson and peers navigating tariffs and inflation.
QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel
QGEN expands its U.S. QIAstat-Dx portfolio with an FDA-cleared panel that detects gram-negative bacteria and resistance markers in about one hour.
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth
Pacemakers and glucose monitors keep selling whether the economy booms or collapses, and three medical device giants have spent decades turning that predictable demand into paychecks that grow every single year. One has raised its dividend for 54 consecutive years and still trades at a rare discount.
BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today marked 70 years of manufacturing in Sandy, Utah, a key part of the company's U.S. manufacturing network and a critical source of the medical technologies healthcare providers and patients depend on for daily care worldwide.
How Big Could BSX Stock's Next Fall Be?
Boston Scientific (BSX) stock has lost more than half its value over the past 12 months, while the S&P 500 returned 18.0%. A subsequent setback occurred in September, when the company said a cyberattack would likely keep it from meeting its guidance. If the wider market turns now, how big could the next fall be, and how long would you wait? The answer depends on how well Boston Scientific is equipped to absorb a broader downturn today.
Here's Why You Should Retain BDX Stock in Your Portfolio for Now
Becton, Dickinson's MedTech transformation, innovation pipeline and strategic partnerships support growth despite reimbursement and macroeconomic pressures.
Best Dividend Aristocrats For October 2026
The ProShares S&P 500 Dividend Aristocrats ETF trails SPY YTD, but 20 individual Aristocrats are outperforming the ETF. Check out the Aristocrats list here.
Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum
Waters (NYSE:WAT) President and Chief Executive Officer Udit Batra said the company’s second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science operations and early progress integrating acquired Becton Dickinson businesses. Speaking at a JPMo
Best Dividend Kings: September 2026
Dividend Kings are underperforming SPY in September, with a -4.22% average return versus SPY's marginal gain.
Dividend Champion, Contender, And Challenger Highlights: Week September 27
Get the weekly summary of dividend changes for Dividend Champions, Contenders & Challengers, plus upcoming ex-dividend and pay dates.
Smoke Evacuation Systems Market Forecasts Growth from $0.20B (2025) to $0.30B by 2031, Profiling CONMED, Medtronic, Stryker & Becton Dickinson
The global smoke evacuation systems market is forecast to grow from USD 0.20 billion in 2025 to USD 0.30 billion by 2031, at a 7.5% CAGR. Growth is driven by rising minimally invasive, electrosurgical and laparoscopic procedures, stricter surgical smoke safety guidance, and demand for better operating room air quality. Smoke evacuation pencils and wands lead the product segment, while laparoscopic surgery holds the largest application share. The US is expected to record North America’s fastest g
Waters: Positive Momentum Rides High Again
Waters has rebounded sharply, with shares rising from $300 to $425 on solid organic and acquired sales growth. Click to read more about the WAT stock here.
How Far Can BSX Stock Swing After Losing More Than Half Its Value?
Boston Scientific (BSX) stock has fallen 55.5% over the past twelve months, and at $43.72 it trades barely above its 52-week low of $42.63. The options market now prices a likely one-year range from $28.46 to $67.16 a share. That band is wide, but it is close to how much the stock has already been moving.
Arthur Hu to Join BD as Chief Information and Digital Officer
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Arthur (Art) Hu has been named executive vice president and chief information and digital officer, effective September 30.
Why Is Becton Dickinson (BDX) Facing Fresh SEC And Litigation Pressure?
Becton Dickinson (NYSE:BDX) reached an SEC cease and desist settlement over past Alaris infusion pump risk disclosures, including a civil penalty and creation of a Fair Fund for investors. Subsidiary C.R. Bard recently faced a plaintiff verdict in Bard PowerPort litigation, with thousands of related product liability cases still pending. The Alaris disclosure settlement and Bard PowerPort verdict both tie into a wider pattern of legal and compliance pressures our research tracks. We have...
Jim Cramer Said These 2 Stocks Were Sold Because Of A Rotation – But Is He Right?
Life sciences solutions and products provider Thermo Fisher Scientific (NYSE:TMO)’s shares have done well in September and are up by more than 8% since the 10th. On the 15th, Cramer discussed the strength in the shares in a conversation with his co-host David Faber amidst the turmoil in the AI sector on the back of […]
The Dividend Kings Ranked By Quality Scores (September 2026)
Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through economic challenges.
Why BSX Stock Lost More Than Half Its Value While Sales Kept Rising
Boston Scientific (BSX) has fallen about 54% since late December 2025, and it now sits at $43.91, just above a 52-week low of $42.63. Device peers were mixed over the same nine months: Abbott lost about 17%, Medtronic barely moved, and Johnson & Johnson rose about 32%. The market repriced Boston Scientific's growth rate after management concentrated its guidance cut in two core product lines.
Has BSX Stock Finally Hit Bottom?
Boston Scientific (BSX) stock has fallen about 57% over the past year, to about $45. The shares now sell for 3.2 times trailing sales, hovering near their decade-long historical trough of roughly 3.0 times and well off their 8.6 high.
BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation
BD expands U.S. pharmacy automation with Vmax 160 at Fairview to handle complex specialty and refrigerated medications.
BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Fairview Health Services has become the first health system in the United States to deploy the BD Vmax 160, a next generation pharmacy automation robot designed to help health systems manage the increasing complexity of specialty therapies and refrigerated medicines in high-volume, centralized outpatient pharmacy operations.
BSX Stock: Is It Time To Buy Or Sell Puts?
Trading near $45 a share, Boston Scientific (BSX) sits roughly 58% below its 52-week peak. Instead of buying the dip outright, selling cash-secured put options allows investors to generate immediate income while locking in an even deeper entry point. Sell a put option on BSX expiring 9/17/2027, with a strike price of $30.
Becton, Dickinson and Company (BDX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Becton, Dickinson and Company (BDX) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:00 AM EDTCompany ParticipantsThomas Polen - President,...
Becton Dickinson & Co's Dividend Analysis
Becton Dickinson & Co (NYSE:BDX) recently announced a total dividend of $1.05 per share, with the ex-dividend date set for 2026-09-09. This cash dividend is payable on 2026-09-30. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure
Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.
Dividend Champion, Contender, And Challenger Highlights: Week September 6
Explore this weekâs dividend updates for Dividend Champions, Contenders & Challengersâsee dividend changes, upcoming ex-dividend and pay dates.
How Much Upside Can BSX Stock's Growth Deliver?
While two high-profile segments - WATCHMAN and Electrophysiology - have stumbled, the market is overlooking the company's core stability. Business units representing roughly 75% of revenue are performing consistently with their historical track record, though this durable base's near-term ~6% growth leaves our 10.8% three-year CAGR reliant on a post-2026 pipeline re-acceleration.
How Is Becton, Dickinson and Company's Stock Performance Compared to Other Medical Devices Stocks?
Becton, Dickinson and Company has notably outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.
Becton Dickinson (BDX) Becomes Founding Sponsor Of Hazardous Drug Data Consortium
Becton Dickinson (NYSE:BDX) has become a founding sponsor of a new Medicinal Hazard Data Standardization Consortium focused on hazardous drug information. The global initiative aims to create standardized Medicinal Hazard Data Sheets to reduce data fragmentation and support safer handling of hazardous medicines for healthcare workers. Several major healthcare companies are joining BD in the consortium, which is expected to influence future regulatory and clinical best practice...
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-28 | Feld Michael | -76 | $183.7 | $13,961 |
| 2026-09-02 | Roque Vitor | -190 | - | - |
| 2026-08-26 | Feld Michael | -165 | $188.49 | $31,101 |
| 2026-08-20 | Feld Michael | -1,049 | - | - |
| 2026-08-13 | Polen Thomas E Jr | -43,278 | - | - |
| 2026-08-13 | Polen Thomas E Jr | -4,152 | $185 | $768,120 |
| 2026-08-13 | Polen Thomas E Jr | -39,126 | $185 | $7,238,310 |
| 2026-08-13 | Polen Thomas E Jr | +43,278 | $167.25 | $7,238,246 |
| 2026-08-11 | Goette Roland | -2,438 | $180.84 | $440,888 |
| 2026-08-06 | Huffines Robert Luther | +189 | $165.62 | $31,302 |
| 2026-08-06 | Byington Carrie L | +94 | $165.62 | $15,568 |
| 2026-07-27 | Feld Michael | -75 | $157.13 | $11,785 |
| 2026-07-02 | Muhsin Bilal | -1,935 | - | - |
| 2026-07-01 | Muhsin Bilal | +14,342 | - | - |
| 2026-06-26 | Feld Michael | -75 | $152.8 | $11,460 |
| 2026-06-24 | Garrison Michael David | -1,100 | $145.66 | $160,226 |
| 2026-06-10 | Garrison Michael David | -1,100 | $151.48 | $166,628 |
| 2026-06-01 | Polen Thomas E Jr | -20,209 | - | - |
| 2026-06-01 | Polen Thomas E Jr | -2,764 | $146.35 | $404,511 |
| 2026-06-01 | Polen Thomas E Jr | -17,445 | $146.15 | $2,549,587 |
| 2026-06-01 | Polen Thomas E Jr | +20,209 | $126.16 | $2,549,567 |
| 2026-06-01 | Menziuso Peter | +14,258 | - | - |
| 2026-05-26 | Feld Michael | -75 | $147.35 | $11,051 |
| 2026-05-08 | Huffines Robert Luther | +210 | $149.04 | $31,298 |
| 2026-05-08 | Byington Carrie L | +105 | $149.04 | $15,649 |
| 2026-05-07 | Roque Vitor | +1,721 | - | - |
| 2026-04-27 | Feld Michael | -74 | $151.94 | $11,244 |
| 2026-04-06 | Neal Shana Carol | -1,146 | - | - |
| 2026-03-26 | Feld Michael | -75 | $156.83 | $11,762 |
| 2026-03-16 | Minnix Lanesha | +7,492 | - | - |
| 2026-03-02 | Roque Vitor | +931 | - | - |
| 2026-03-02 | Spikner Pamela L. | +931 | - | - |
| 2026-02-26 | Feld Michael | -75 | $181.84 | $13,638 |
| 2026-02-18 | SCOTT BERTRAM L | -953 | $182.61 | $174,027 |
| 2026-02-04 | Huffines Robert Luther | +100 | $201.91 | $20,191 |
| 2026-02-04 | Byington Carrie L | +30 | $201.91 | $6,057 |
| 2026-02-04 | Jones Christopher Ian Montague | +272 | $201.91 | $54,920 |
| 2026-01-27 | Henderson Jeffrey William | +1,098 | - | - |
| 2026-01-27 | ECKERT R ANDREW | +1,098 | - | - |
| 2026-01-27 | Byington Carrie L | +1,098 | - | - |
| 2026-01-27 | HAYES GREGORY | +1,098 | - | - |
| 2026-01-27 | Brown William M | +1,098 | - | - |
| 2026-01-27 | Huffines Robert Luther | +1,098 | - | - |
| 2026-01-27 | Jones Christopher Ian Montague | +1,098 | - | - |
| 2026-01-27 | RING TIMOTHY M | +1,098 | - | - |
| 2026-01-27 | SCOTT BERTRAM L | +1,098 | - | - |
| 2026-01-27 | Waldstreicher Joanne | +1,098 | - | - |
| 2026-01-27 | Wright Jacqueline | +1,098 | - | - |
| 2026-01-26 | Feld Michael | -75 | $202.73 | $15,205 |
| 2026-01-21 | Spikner Pamela L. | -84 | - | - |
| 2026-01-15 | Garrison Michael David | -3,054 | - | - |
| 2026-01-15 | Garrison Michael David | -1,010 | $206.54 | $208,605 |
| 2026-01-15 | Garrison Michael David | -600 | $209 | $125,400 |
| 2026-01-15 | Garrison Michael David | -2,454 | $209 | $512,886 |
| 2026-01-15 | Garrison Michael David | +3,054 | $167.91 | $512,797 |
| 2026-01-03 | Shan David | -44 | - | - |
| 2025-12-26 | Feld Michael | -74 | $196.08 | $14,510 |
| 2025-12-17 | Garrison Michael David | -629 | $196.03 | $123,303 |
| 2025-12-01 | Feld Michael | -75 | $193.36 | $14,502 |
| 2025-12-01 | Wright Jacqueline | +180 | - | - |
| 2025-12-01 | Huffines Robert Luther | +180 | - | - |
| 2025-11-26 | Mocherla Pavan Kumar | +708 | - | - |
| 2025-11-26 | Mocherla Pavan Kumar | +2,208 | - | - |
| 2025-11-26 | Shan David | -134 | - | - |
| 2025-11-26 | Shan David | +1,025 | - | - |
| 2025-11-26 | Shan David | +3,504 | - | - |
| 2025-11-26 | Neal Shana Carol | -2,454 | - | - |
| 2025-11-26 | Neal Shana Carol | +3,525 | - | - |
| 2025-11-26 | Neal Shana Carol | +6,727 | - | - |
| 2025-11-26 | Goette Roland | -138 | - | - |
| 2025-11-26 | Goette Roland | +1,237 | - | - |
| 2025-11-26 | Goette Roland | +1,906 | - | - |
| 2025-11-26 | Garrison Michael David | -1,769 | - | - |
| 2025-11-26 | Garrison Michael David | +3,048 | - | - |
| 2025-11-26 | Garrison Michael David | +7,568 | - | - |
| 2025-11-26 | Feld Michael | -419 | - | - |
| 2025-11-26 | Feld Michael | +8,829 | - | - |
| 2025-11-26 | DelOrefice Christopher | -4,245 | - | - |
| 2025-11-26 | DelOrefice Christopher | +6,006 | - | - |
| 2025-11-26 | Byrd Richard | -1,719 | - | - |
| 2025-11-26 | Byrd Richard | +2,385 | - | - |
| 2025-11-26 | Byrd Richard | +6,447 | - | - |
| 2025-11-26 | Muhsin Bilal | +9,530 | - | - |
| 2025-11-26 | Polen Thomas E Jr | +165,581 | - | - |
| 2025-11-26 | Polen Thomas E Jr | -17,421 | - | - |
| 2025-11-26 | Polen Thomas E Jr | +22,521 | - | - |
| 2025-11-26 | Spikner Pamela L. | +1,234 | - | - |
| 2025-11-07 | SCOTT BERTRAM L | -217 | $176.58 | $38,318 |
| 2025-11-04 | Byington Carrie L | +34 | $178.71 | $6,076 |
| 2025-11-04 | Jones Christopher Ian Montague | +168 | $178.71 | $30,023 |
| 2025-10-27 | Feld Michael | -57 | $186.01 | $10,603 |